Request fot quotation – RFQ Z2/5438/1 – Study monitoring – Empagliflozin

In connection with the implementation of the project 2022/ABM/04/00014-00 – „Opracowanie i rozwój produktu leczniczego z substancją czynną EMPAGLIFLOZYNĄ – leku generycznego na cukrzycę typu 2” (”Design and development of a medicinal product with the active substance EMPAGLIFLOZIN – a generic drug for type 2 diabetes”), Tarchominskie Zakłady Farmaceutyczne POLFA S.A. invites you to submit bids for the below specified subject of the contract.

The project is financed from the state budget as part of a grant awarded by the Medical Research Agency.

More information can be found on the Tenders subpage.